News
Never-smokers exposed to high levels of fine particulate air pollution have a significantly greater risk of developing lung ...
6hon MSN
Precision nanobody acts as 'drone strike' against lung cancer cells, minimizing side effects
A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, ...
ASHLAND — UK King’s Daughters is now offering the Ion Endoluminal System, a robotic-assisted platform that provides a safer, ...
Firefighters have a dangerous job, and their risk for death goes beyond the blazes they face.An American Cancer Society ...
Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...
The Canadian Press on MSN1d
Lung cancer survival rate has doubled, but it still causes the most cancer deaths: StatCan
Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients ...
1d
WSPA 7News on MSNAsk the Expert: The importance of lung cancer screenings
Lung cancer is the second most common form of cancer in the United States, but doctors said it’s the deadliest. As part of ...
Dean Comstock was 27 when he received the frightening diagnosis of terminal lung cancer. The singer and runner had never ...
Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...
3h
TipRanks on MSNBioNTech’s Phase II Study on BNT327: A Potential Game-Changer in Lung Cancer Treatment
The study tests BNT327, an investigational drug administered via intravenous infusion, in combination with standard chemotherapy drugs like etoposide, carboplatin, paclitaxel, and topotecan. The goal ...
Abhinav Agrawal, MD, discusses findings from a multidisciplinary expert panel on endoscopic lung and lymph node biopsies that show how changes in biopsy methods have affected comprehensive biomarker ...
3h
TipRanks on MSNAbbVie Advances in Lung Cancer Treatment with New Clinical Study
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results